Dr. Jan-Shiang (Jesse) Taur currently serves as a staff fellow at Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration. Dr. Taur is responsible for assessing the bioequivalence portion of Abbreviated New Drug Application. Before joining the federal government in 2014, Dr. Taur is a scientist at Eisai Inc. responsible for characterizing the profiles of drug metabolism and pharmacokinetics for drug candidates.

Dr. Taur earned his bachelor degree from the National Cheng Kung University (Taiwan, ROC). He earned his MS in statistics and his PhD degree in pharmaceutical sciences from Oregon State University (Corvallis, OR).

Elaine H. Chang Esq. is the founding partner of the “Law Offices of Elaine H. Chang” and Urbini Group, LLC, a company that provides legal and consulting services. For more than three decades, Ms. Chang has provided business start-up as well as merger and acquisition consultations for international corporate clients in establishing business operations and investments in both Asia and the United States. Her work also includes assisting clients i obtain working visas for long term stays and permanent residence in the US through employments or family-based proceedings.

In addition, Ms. Chang has been serving as Senior Executive Vice President and General Counsel of AmeriSci Group, one of the largest environmental testing companies in the US. She leads a team responsible for business explorations between Asia and the United States, focusing on environmental, consumer product, and food safety compliance in relation to the Food and Drug Administration (US-FDA), Department of Agriculture (USDA), and international trading laws. (http://www.amerisci.com)

In the Greater Washington DC Metro area, Ms. Chang has been a long-time volunteer for many non-profit charities, professional communities, and alumni associations. For instance, Ms. Chang has committed her efforts to the Monte-Jade Science and Technology Association-DC Chapter, where she served as the Chairperson from 2008 to 2009. She was also an Executive Board member of Global Monte-Jade, serving its 15 worldwide chapters, including chapters in the US, Canada, Taiwan, Hong Kong, Singapore, and China.

In 2000, when Ms. Chang served as the Chairperson of the Taipei First Girls High School Alumni Association in DC area, she created the database that facilitated global communications among members. She led the Board of Directors to initiate co-op events with other alumni associations, which have been expanding multi-fold since. Ms. Chang also served as the leader of the University of National Chengchi Univ. Alumni Association during 2018-2019. Ms. Chang established Washington DC’s Friendship Club for the China Youth Corp (www.cyc.org.tw), an organization that initiates and support events that aim to benefit the next generation in Taiwan and beyond.

Internationally, Ms. Chang has been practicing law in Taiwan and in the USA. She received her LL.M from Georgetown University Law Center in Washington D.C. and her Master of Law and Bachelor of Law degrees from the National Cheng-Chi University Law School in Taipei, Taiwan. Before practicing law in the United States, Ms. Chang had served as a District Court Judge and a Public Prosecutor in Taiwan.

In the academic sphere, Ms. Chang was a lecturer of law at Ming Chuan College and Shih Chien College in Taiwan. She also taught Chinese at TECRO Chinese school and participated in the Welcome to Washington DC Club for diplomats.

Ms. Chang has always been enthusiastic in helping recent graduates from university discover their career goals and reach their dreams in the United States; she is currently pursuing goals of supporting bilingual education in Taiwan.

Dr. Liu is currently a Senior Health Physicist at Leidos, a consulting firm working extensively with DoD. She is a Certified Health Physicist and has more than 15 years of industrial, academic, and regulatory compliance experience encompassing radiological dose reconstructions, risk characterization, environmental remediation, regulatory and leadership with environmental consulting firms, U.S. National Laboratories, and universities.

Dr. Liu successfully established the statistical operating procedure for evaluating environmental radiological data complicated by chemical pollutants at various DOE sites. She also built up an analytical system based on the state-of-the-art radiological instrumentation capability for a large-scale remediation plan at DOE Hanford facility. She held a professorship at health physics and medical physics graduate programs of School of Mechanical Engineering at Georgia Tech. Dr. Liu’s research includes radiological hazards from CT scans, transmission of I-131 to infants through breast milk, age-dependent internal dosimetry, and emergency response management exercises in connection with radiological dispersion devices. Dr. Liu has over 50 articles, papers, reports and presentations.

She received her B.S. in physics and M.S. in health physics from National Tsing-Hua University, Hsinchu, Taiwan, and Ph.D. in environmental health engineering from Northwestern University, Evanston, Illinois.

Dr. Nelson Lu is a mathematical statistician at the Center for Devices and Radiological Health at the US Food and Drug Administration. He has been reviewing applications of cardiovascular, ophthalmological, and ear, nose, and throat medical devices, conducting research, giving presentations in various statistical and clinical conferences, and organizing sessions for some statistical conferences.

Prior to joining the FDA, he spent six years working with Wyeth Research (now Pfizer). He received his Ph.D. in Statistics and M.S. in Actuarial Science from the University of Iowa and Bachelor of Science in Mathematics from National Taiwan University.

• President and founder of Taiwanese-American First Responders Benevolent Organization (TAFR)
• Treasure of FBI DC Citizen Academy Alumni Association (FBIDCCAAA)
• Promotion Committee Member of Overseas Community Affairs Council of Taiwan
• Member Director of Taiwan US Cultural Association
• Volunteer at Occupational Knowledge International
• Volunteer at NIH Children Hospital
• Vice President of CF Alliance Insurance Services, LLC
• Associate at RE/MAX Professionals
• Owner of Fung Enterprises, LLC

Jackie Fung-Mildiner, aka Jackie Fung, is the President and founder of the Taiwanese American First Re-sponders Benevolent Organization (TAFR). Jackie formed TAFR in 2016, after volunteering with col-leagues at the 2015 World Police and Fire Games in Fairfax, Virginia. With the assistance of co-founder and Vice-President Raymond Lee, Jackie works to increase knowledge, information exchange, and raise funds for badly-needed first responder equipment around the world. In addition to benevolent work through TAFR, Jackie is an active member of the community, championing a number of significant causes, including environmental cleanup, and support for individuals with illnesses and disabilities. As an insurance professional based out of Maryland, Jackie consistently assists people fac-ing difficult situations. Jackie has over 14 years of experience in the insurance industry, with the current insurance agency servicing CA, DC, MD, and VA. Recently, Jackie obtained her realtor license. Jackie has a bachelor’s degree in International Business and Finance from George Washington University, a master’s degree in Business Administration from the University of Maryland University College, and is a graduate of the Federal Bureau of Investigation’s Citizen’s Academy. She is also the FBI DC Citizen Academy Alumni Association’s Treasurer, a task that shows her dedication to serve the community.

Dr. Yow-Ming Wang is currently the Associate Director for Biosimilars and Therapeutic Biologics and has been Director/co-Director of Therapeutic Biologics Program since September 2017 in the Office of Clinical Pharmacology at the FDA. Dr. Wang served as the team leader of Biologics Team in the former Division of Clinical Pharmacology III (2011-2017); the Biologics Team was responsible for reviewing submissions of biological products in three clinical divisions. Prior to FDA, she worked at Amgen (2004 to 2011), Vertex Pharmaceuticals (1995-2004), and Parke-Davis Pharmaceutical Research of Warner Lambert Company (1993-1995). Her industry experience spanned drug discovery, preclinical and clinical development, and post-marketing evaluations of small and large molecules. She received her PhD degree from The Ohio State University College of Pharmacy with a research focus on Pharmacokinetics and Biopharmaceutics, Master degree in pharmacology from Kaohsiung Medical College in Taiwan, and Bachelor degree in pharmacy from National Taiwan University.

Apollo Teng is currently the Geographic Information Systems (GIS) Manager with the Montgomery County Government. He started the management position with GIS, a section of the Department of Technology Services, in January 1993. In 2006, he was selected (from the County Government’s 9,000+ workforce) for the Award for Exceptional Service along with three co-workers. Since 1979 his GIS team has won 35 NACo (National Association of Counties) Achievement Awards (IT Category).

Mr. Teng has also taught part-time at Columbia University (Statistical Methods for Planners), Alabama A&M University (Quantitative Methods and GIS), and Montgomery College (Introduction to GIS). Mr. Teng is a member of the American Society for Photogrammetry and Remote Sensing (ASPRS). He held three positions with the ASPRS Potomac Region (1,000 members): Secretary/Treasurer (1996), Vice President (1997), and President (1998). The Potomac Region was selected by the ASPRS (national) Executive Committee as “Region of the Year” for 1998.

Mr. Teng was CAPA Secretary for 2007 and VP for 2008. He holds degrees of Bachelor of Architecture (1965) from Chung Yuan University, Taiwan; Master of City Planning (1972) from MIT; and is an “ABD” (All But Dissertation) from Columbia University, New York City. Mr. Teng attended the Second Annual Symposium on National Construction and Development (中華民國國家建設硏究會, 簡稱「國建會) Taipei, Taiwan, ROC, 1973 and the 1987 Chinese American Academic & Professional Conference, CAAPCON 1987 (第二屆北美華人學術研討會, 俗稱「海外國建會」) Houston, USA, 1987.

“Apollo (阿波羅)” used to be his pen name. He also used it while applying for his ROC passport and US visa back in the 1970’s and the name has stuck with him ever since. Mr. Teng is married to Lily Huang (黃麗梅). They have three adult daughters.

Edward Wan, PhD is the 2013 CAPA Sr. Advisor. Previously, he also served as the 2010 and 2012 CAPA Sr. Advisor and was the 2011 CAPA President. In 2010, he help prepared a winning proposal to secure $13 k funding from the National Science Council in Taiwan to finance a successful 2010 CAPA Annual Symposium, in which he also played the role of Chairperson for organizing an Energy Session. During his tenure as the 2011 CAPA President, he was instrumental to raise $18k to fund the publication of a CAPA 36th Anniversary Commemorating Book. In 2012, he served as the overall coordinator to organize the first “Asian Job Fair” which was supported by CAPA and four other Chinese American community organizations (i.e. MJ-DC, OCA-Dc, CCACC and TCCGW). Again, in February 2013, he served as the principal organizer for a successful Asian “Internship Seminar”, which was supported by the same five organizations plus TECRO and TSA. For the past three decades, Dr. Wan has been actively involved with several Chinese and American organizations including serving as the first treasurer of the Gaithersburg Chinese School and the past President of Chien Chun Alumni Association (CCAA) during 2009-2010. He supported the equal rights and justice for all Asian Americans and was the past President of OCA-DC and an Executive VP of OCA National. He also served on the Board of Leadership Montgomery and currently is a member of Board of Visitors at the University of Maryland. Professionally, Dr. Wan has been engaged in energy & environmental consulting business for over 35 years.

He was the founding President of STR Pacific Corporation, an international energy and environmental consulting company, which has done businesses in the US, Taiwan and China. Prior to starting his own company, he worked for Bechtel, SAIC, and MITRE Corporation. Dr. Wan received BS from Chun Yuan University and Ph.D. from the University of Maryland, all in Chemical Engineering.

Dr. Chang is a veterinarian, veterinary pathologist, veterinary pharmacologist, and toxicologist by training and a self-trained bioanalytical chemist. From 2008-2012, Dr. Chang serves as a regulatory safety reviewer at the Division of Animal Feeds, Office of Surveillance and Compliance, Center for Veterinary Medicine (CVM), US Food and Drug Administration, responsible to regulate and review safety of the use of new animal-feed ingredients and assessed the health hazard of incidences of adulteration and/or misbranding of animal feed products in the US. In June 2012, he joined the oncology drug review team of the Center for Drug Evaluation and Research (CDER) of FDA to assist with the premarket, nonclinical safety/efficacy review of candidate cancer drugs. Before joining the Federal government in 2008, Dr. Chang had directed development of biomedical products in biopharmaceutical industry, interacted with FDA, and launched clinical trials; assisted in building toxicogenomics database in bioinformatic industry for predicting safety of candidate new chemical entities; and managed contract research projects/programs and directed non-clinical safety studies within contract research industry.

Dr. Chang earned his veterinary medicine degree from the National Taiwan University (Taiwan, ROC), his first MS in veterinary pathology from University of Minnesota (St. Paul, MN), and his second MS and his PhD degrees in veterinary physiology/pharmacology from The Ohio State University (Columbus, OH). He spent three years afterward conducted postdoctoral research at a Wake Forest University/RJR Tobacco joined Leon Golberg Fellowship program (Winston-Salem, NC).

Dr. Chang is the inaugural and current Chair for the Biomed/Biotech Special Interest Group (SIG) of Section 509 (DC and Central MD) of the American Society for Quality , the President of the Chinese American Professional Association of Metropolitan DC (www.capadc.org), and the Vice President for Biomed/Biotech SIG of the Monte Jade Science and Technology Association for the Greater Washington.

Education

• B.A. and M.A., Political Science, Taiwan University（台灣大學政治學學士和碩士）
• M.B.A., Carey Business School, Johns Hopkins University（約翰霍普金斯大學企管碩士）
• J.D., South Texas College of Law （南德州法學院法學博士）

Profession: Attorney at Law (律師)

Dr. Ray Hwang practices law in the following areas:

• Estate and Trusts
• Intellectual Property
• International Taxation and Trade
• Real Estate

Dr. Woei-jyh (Adam) Lee received BSE degree from the National Taiwan University, MS degree from the Courant Institute at New York University, and PhD degree from the University of Maryland at College Park (UMD). He worked on distributed objects and fault tolerance at the AT&T Labs - Research in 1997. He focused on network software and management at the Bell Laboratories Research from 1998 to 2000. He visited the University of Southern California specializing in continuous media streaming and multimedia networking from 2002 to 2003.

He contributed in protein domain parsing and boundary prediction at the National Cancer Institute (NCI), National Institutes of Health (NIH) from 2004 to 2005. He was a fellow focusing on human genetics and genomics at the National Center for Biotechnology Information, National Library of Medicine, NIH from 2009 to 2012. He became a special volunteer working on computational modeling for cancer progression and metastatic at the NCI, NIH from 2012 to 2013. He was also affiliated with the Center for Bioinformatics and Computational Biology and the Institute for Advanced Computer Studies at UMD.

He is currently a faculty of Information Systems at the Robert H. Smith School of Business at UMD since 2012. His research interests include information integration, data management and mining, literature-based discovery, performance simulation and evaluation, bioinformatics and computational biology, human genomics and genetics, and cancer biology. He has two US Patents and is a member of the ISCB, the IAENG, and the CAPA.

Dr. Alven Lam (林雄生) is Director of International Markets at Ginnie Mae, the United States Department of Housing and Urban Development (HUD) in Washington D.C. He is responsible for developing and implementing international investors strategic engagement plan outreaching to Ginnie Mae’s overseas stakeholders including private and public institutions with direct and indirect decision making authorities to the investments of US$1.5 trillion GNMA securities.

Mr. Lam served as Director of International Research at HUD from 2002 to 2013. In 2001, he managed the U.S.-China Housing Initiative, a Presidential bilateral collaboration between HUD and the Chinese Ministry of Housing and Urban-Rural Development with the focuses on finance and building technology. He developed international collaboration projects with United Nations Habitat Program, Asia Pacific Economic Cooperation, and the Governments of Spain, Mexico, Canada, Uganda, Ghana, El Salvador, Japan, Korea, and other multilateral banks and international organizations.

He has served in the U.S. delegations the UN-Habitat Governing Council, UN Commission on Sustainable Development, UN Commission for Population, and the World Urban Forum in Spain, Canada, and Brazil. Since 2010, Mr. Lam has been actively participated in the Energy Work Group within the Asia Pacific Economic Cooperation (APEC) and has served on the U.S. Delegation to Tianjin, China, San Francisco, Kaohsiung, Chinese Taipei on low-carbon city projects. Within the APEC framework, he has also developed a U.S.-Chinese Taipei collaboration project on knowledge sharing platform to support President Obama’s Energy Smart Community Initiative (ESCI) in Asia.

Prior to joining HUD, Mr. Lam was research fellow at the Lincoln Institute of Land Policy in Cambridge, Massachusetts. Mr. Lam received B.S. degree from National Cheng Kung University, Master’s degree from Ohio State University, and a doctoral degree from Harvard University Graduate School of Design.

Dr. Chung-Chu Teng (鄧中柱) is the Division Chief of National Oceanic and Atmospheric Administration’s (NOAA) Center for Operational Oceanographic Products and Services’ (CO-OPS) Engineering Division. Prior to joining CO-OPS, he has worked for NOAA’s National Data Buoy Center as the Observing Systems Branch Chief, Chief Engineer, and Program Manager for 22 years. He also has been an adjunct professor at the Marine Science Department of University of Southern Mississippi since 1995, where he taught several graduate courses and served on many graduate committees.

Dr. Teng has authored more than 70 technical and scientific papers and numerous technical reports in the area of ocean science, engineering, and technology. He is serving and served on many national and international advisory or technical committees. He has made numerous presentations at various conferences, meetings, and workshops. Dr. Teng is a registered Professional Engineer and holds a U.S. Patent on an ocean surface wave measurement system.

Currently, Dr. Teng is a board director of the Chinese Culture and Community Service Center (CCACC). He was the President and a board director of the Chinese-American Oceanic and Atmospheric Association which has more than 600 members in U.S., Taiwan, China, Hong Kong, and several other countries. He was the President and continues to serve as a board director of the National Cheng-Kung University (NCKU) Alumni Association in the Great Washington DC area. In 2013, he received the Outstanding Alumni award from the NCKU Alumni Association in North America.

Dr. Teng received his M.S. and Ph.D. degrees in ocean engineering from Oregon State University. He received his B.S. degree in hydraulics and ocean engineering from National Cheng-Kung University.

Dr. Chih-Hsuan Wei is currently a research fellow at the National Center for Biotechnology Information (NCBI) in National Institutes of Health (NIH). He received his M.S. degree from the National Tainan University, Taiwan, R.O.C. in 2007. He received his Ph.D. degree in Computer Science from the National Cheng-Kung University, Taiwan, R.O.C. in 2013. In 2013, he obtained Ph.D. dissertation awards in three computer science related categories (i.e., Natural Language Processing, Artificial Intelligence, Information & Computing Machinery) from the Taiwan scientific societies for his excellent performance of the Ph.D. dissertation.

Dr. Wei has authored/co-authored over 40 peer reviewed scientific articles, conference/workshop papers in journals such as Nucleic Acids Research, Bioinformatics, PLoS ONE, BMC Bioinformatics, and Database (Oxford) journals, and reviewed 20 journal/conference papers. He is a very active researcher in biomedical text mining category. He obtained excellent performances in BioCreative and BioASQ biomedical text mining competitions several times and developed several powerful and useful systems which are widely used around the world. Until present, his works has been cited over 500 times. His research interests are bioinformatics, text mining, data mining and machine learning fields.

After receiving his PhD in genetics, he did seven-year postdoctoral research in Drosophila and human genetics. He started working for the biotech company Promega for 12 years as technical service scientist and field application specialist.

He also spent three years in a Taiwan biotech company as R&D and Marketing Director.

Charlie Pan received his MS degree in Civil Engineering from National Taiwan University and MS degree in Computer Science from University of Minnesota. He currently works for NASDAQ as a senior system specialist.

He is currently the web master for the following organizations:

• Chinese-American Professionals Association (CAPA) 華府國建聯誼會
• BEINU Alumnae Association of Greater Washington Area 大華府區北一女校友會
• Washingtion School of Chinese Language and Culture (WSCLC) 華府中文學校